End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,536 KRW | -4.24% | -12.58% | -59.15% |
Jun. 10 | Shaperon and Dong-A St Sign MOU for Nanobody-Based New Drug Development | CI |
Mar. 18 | Shaperon Enrolls its First Patient in Phase 2 U.S. Clinical Trial for Atopic Dermatitis Therapy 'Nugel' | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
26.73M | - | - | - | - | - | |
121B | ||||||
110B | ||||||
25.93B | - | |||||
19.27B | - | |||||
16.01B |
- Stock Market
- Equities
- A378800 Stock
- Charts Shaperon Inc.
- Sector Chart